Interview with Douglas B. Johnson, MD, author of Chronic Immune-Related Adverse Events Following Adjuvant Anti–PD-1 Therapy for High-risk Resected Melanoma
JAMA Oncology Author Interviews JAMA Oncology Author Interviews JAMA Oncology Author Interviews